Regenerative medicine clinic economics: is it actually profitable?

A wide spread hiding inside one menu

A regenerative or orthobiologics clinic looks, from the outside, like a single high-value business: cash prices that run from a few hundred dollars into the low thousands, no insurance friction, and patients who arrive already willing to pay out of pocket. Under that surface, though, the menu holds some of the widest economic spread of any cash-pay vertical. A platelet-rich plasma (PRP) visit and an expensive biologic injection can sit on the same price list, run in the same room, and yet contribute wildly different amounts per hour of provider time.

That spread is the whole story. The clinics that do well are not necessarily the ones charging the most per procedure. They are the ones who understand which procedures actually convert provider time into profit, and who build their schedule, pricing, and room turnover around that. This piece walks the economics procedure by procedure, then pulls out the levers that decide whether the model is genuinely profitable.

One note before the numbers. This is strictly a piece about economics. It makes no claim about whether any of these procedures work, for whom, or under what circumstances; the clinical evidence is contested and the regulatory landscape shifts. Every figure below is illustrative and meant to show structure, not to quote a market rate. Run your own.

The four cost components behind every procedure

Whatever the procedure, the economics come down to the same four components. What separates a PRP visit from a biologic injection is not the list; it is how heavily each line weighs.

• Cash price. High and set by you, with no payer to negotiate it down. This is the lever you control most directly, and the one most clinics set by looking sideways at competitors rather than at their own cost and time.
• Consumable cost. The variable cost per procedure, and the line with the most range. A PRP kit is modest. A biologic vial can cost more than an entire PRP visit charges. This single line is what turns two same-priced procedures into very different businesses.
• Provider and procedure time. Regenerative work is rarely a quick injection. A typical visit can involve a blood draw, spinning it down in a centrifuge, preparing the sample, and injecting, sometimes under ultrasound guidance. That is real, multi-step provider time, and it is the constraint that caps how many procedures a day can hold.
• Capital. The centrifuge and, more significantly, the ultrasound. These are upfront costs that do not change per procedure, but they have to be earned back, and they shape which procedures you can credibly offer at all.

Hold those four in mind and the right metric falls out naturally. The question is not what a procedure charges, and not even what it nets per visit. It is what it nets per hour of the provider time it consumes, because provider hours are the fixed, scarce resource the whole clinic runs on.

Profit per provider-hour is the metric that ranks the menu

Across cash-pay practices, the single most honest measure of a service is profit per provider-hour: what is left after the direct cost to deliver a procedure, divided by the provider time it actually ties up. For a regenerative clinic this metric matters more than almost anywhere else, precisely because the consumable cost and the procedure time swing so hard between procedures.

Profit per provider-hour = (cash price minus direct cost) divided by provider-hours consumed

A $750 procedure with a $60 consumable that runs in 45 minutes and a $4,500 procedure with a $1,900 consumable that runs in 75 minutes are not ranked by their price tags. They are ranked by what each leaves per hour of the same scarce provider time. Sometimes the cheaper procedure wins that contest, and sometimes the expensive one does. You cannot know which without running the number, and the answer reorders your menu. For the full mechanics, see how to calculate profit per provider-hour.

Walking the menu, procedure by procedure

Here is the spread laid out across four common procedure types. Every number is illustrative and rounded for clarity; the point is the structure, not the rate. Your prices, your kit costs, and your real minutes will differ.

An efficient PRP visit: the workhorse

Take a PRP injection priced at roughly $750. The kit and draw supplies cost on the order of $60. The full visit, draw, spin, prepare, and inject, takes about 45 minutes of provider time. The direct contribution is $750 minus $60, or $690. Spread across 0.75 of an hour, that is $920 per provider-hour. That is a strong number, and it is why an efficient PRP practice can be a genuinely good business. The consumable is light, the price is high, and the time, while real, is contained.

The fragility in that figure is the word efficient. If the same visit sprawls to 75 minutes because the draw, the spin, and the room turnover are not tight, the same $690 contribution now spreads across 1.25 hours and falls to about $552 per provider-hour. Same price, same kit, same procedure, roughly a 40 percent haircut on profit per hour, caused entirely by time. In this vertical, minutes are money in a very literal sense.

A biologic injection: high price, heavy consumable

Now a biologic procedure priced at roughly $4,500. The vial and supplies run on the order of $1,900. The visit takes about 75 minutes, often including ultrasound guidance. Contribution is $4,500 minus $1,900, or $2,600. Across 1.25 hours, that is $2,080 per provider-hour, well above the PRP figure in absolute terms.

But the structure is different and more exposed. The consumable is more than 40 percent of the price, so margin compresses fast if you ever have to discount, if vial costs rise, or if any product is wasted. A PRP visit you can discount 15 percent and still keep most of the contribution. A biologic procedure where the consumable is already 40-plus percent of the price has far less room to absorb a discount before the economics turn thin. High price does not mean safe margin; it means a bigger gross number sitting on top of a bigger cost you have to clear first.

Prolotherapy and peptide visits: lighter consumable, recurring cadence

Prolotherapy sits closer to the PRP end on consumable cost: the injected solution is inexpensive, so most of the price converts to contribution. A session priced at, say, $350 with a few dollars of supplies and about 30 minutes of provider time clears roughly $345 over 0.5 hours, or about $690 per provider-hour. The catch is that these protocols often run as a series, so the real economics are a course of visits, not one. That cuts both ways: predictable repeat cadence is good for the schedule, but each individual session is lower-ticket, so room turnover and booking density matter even more.

Peptide therapy is a different shape again, closer to a recurring product and follow-up model than a procedure: lower per-visit provider time, modest recurring revenue, and economics that depend on the supply cost and the follow-up cadence rather than on a multi-step injection. Treat it as its own line and do not assume the PRP math carries over. (Availability and rules around some of these products shift; this is purely about how the unit economics behave, not a claim about access.)

Shockwave: low consumable, delegable time

Some clinics add shockwave or similar device-based therapy. The economics invert the biologic case: near-zero consumable, lower price per session (illustratively $200), and short, protocol-driven time of around 20 minutes. Contribution is roughly $190 over a third of an hour, or about $570 per provider-hour if a provider runs it. The real advantage is that this work is often delegable to a trained technician, which means it can fill the schedule without consuming the scarce provider hours your high-ticket injections need. A delegable, low-cost session is worth more to the clinic than its per-hour figure suggests, because it frees the constraint.

Reading the spread

Lined up, the illustrative numbers tell a clear story. None of these is a target; they show how differently same-room procedures can behave.

• Efficient PRP: about $920 per provider-hour, light consumable, contained time. The workhorse.
• Slow PRP: about $552 per provider-hour. Same procedure, lost to time. Avoidable.
• Biologic injection: about $2,080 per provider-hour, but on a heavy consumable with little discount headroom.
• Prolotherapy: about $690 per provider-hour per session, run as a series.
• Shockwave: about $570 per provider-hour if provider-run, and far more valuable when delegated.

The lesson is not that one procedure is best. It is that price alone tells you almost nothing, and that the levers are different for each: time for PRP, consumable and discount discipline for biologics, booking density for prolotherapy, and delegation for shockwave. A clinic that treats the whole menu with one pricing and scheduling reflex leaves money on every line. For the wider version of this point across services, see which of your cash-pay services actually make money.

The levers that decide whether the model is profitable

Profit per procedure is set in the room. Profit for the clinic is set by four levers applied across the whole menu.

1. Procedure mix. Because the per-hour spread is so wide, the mix of what you run is the largest single driver of clinic profit. A schedule weighted toward efficient PRP and well-priced biologics behaves very differently from one dominated by long, low-ticket sessions. You do not control demand entirely, but you control how you present, package, and schedule the menu, and that shapes the mix more than most owners realize.
2. Room and turnover efficiency. The slow-PRP example is the whole argument: 30 extra minutes turned a $920 procedure into a $552 one. Tightening the draw, the spin time, and the room reset is not a cosmetic improvement; it is a direct increase in profit per hour with no change to price. This is the cheapest profit in the building.
3. Pricing for the time consumed. A multi-step procedure that ties up 75 minutes has to be priced for 75 minutes, not anchored to a quick-injection mental model. Price from your cost, your real minutes, and a target profit per hour, not from the clinic down the road. The method is the same one laid out in how to price for a target profit per hour; the inputs are just yours.
4. Consumable and discount discipline. On heavy-vial procedures, the consumable is the margin. Negotiating vial cost, minimizing waste, and resisting the reflex to discount a high-ticket procedure all protect a line that has little room to give. A 15 percent discount on a procedure whose consumable is already 40 percent of the price cuts deep into what is left.

The same procedure can clear $920 an hour or $552 an hour depending only on how long the room takes. In a regenerative clinic, the schedule is the margin.

A note on capital, and on what you put in the ad

The centrifuge is a modest, quickly-earned-back cost. The ultrasound is the capital line that deserves real thought: it is meaningful upfront, it enables certain procedures, and it adds time per visit. Treat it the way you would any device, by asking how many guided procedures at your real margin it takes to earn it back, and over what window at your realistic booking rate. The discipline is the same one any device decision needs; see the device-payback reasoning in how to know if a service is worth offering.

Separately, and importantly: the economics of this vertical can tempt marketing claims the evidence does not support. That is a business risk, not just a compliance one. Pricing and demand built on overstated promises are fragile, and the regulatory posture around regenerative claims can change. Keep the marketing to what you can defend, and let the economics stand on procedure mix, efficiency, and honest pricing rather than on the strength of the promise. A model that only works if the claims are loud is not a durable model.

So, is a regenerative medicine clinic profitable?

It can be, and the better question is which parts of it are. An efficient PRP practice with tight room turnover and time-based pricing can be a strong per-hour business. A biologic line can post large per-hour numbers as long as the consumable is controlled and the discounting stays disciplined. A clinic that runs long visits, prices off competitors, and discounts its heaviest-consumable procedures can be busy and still thin. Profitability here is not a property of the vertical; it is a property of the mix and the minutes.

The way to see it is to rank your actual procedures by profit per provider-hour and look at the spread, the same way the Inside Look walks through a sample practice that looks healthy from the top, ranks every service by what it really contributes per hour, and lets you re-price a procedure, tighten its time, or change the mix and watch profit move, all without adding a single patient. If you want the foundation underneath all of it, start with why financial clarity is the difference between a busy clinic and a profitable one, then read profit per provider-hour for the metric that ranks your whole menu.